Compile Data Set for Download or QSAR
Report error Found 1097 Enz. Inhib. hit(s) with all data for entry = 10999
TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583581BDBM583581(US11524959, Compound 473.)
Affinity DataIC50: 5nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583839BDBM583839(US11524959, Compound 731.)
Affinity DataIC50: 6nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 584177BDBM584177(US11524959, Compound 1069.)
Affinity DataIC50: 6nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 584086BDBM584086(US11524959, Compound 979. | US11524959, Compound 9...)
Affinity DataIC50: 7nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583500BDBM583500(US11524959, Compound 392. | methyl 6-(2-{5-[(1R,4R...)
Affinity DataIC50: 9nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583961BDBM583961(US11524959, Compound 853.)
Affinity DataIC50: 9nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583204BDBM583204(US11524959, Compound 96. | N-[3-(2-(5-[(1R,4R,7R)-...)
Affinity DataIC50: 10nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583501BDBM583501(US11524959, Compound 393. | 4-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 11nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583495BDBM583495(US11524959, Compound 387. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 11nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583503BDBM583503(US11524959, Compound 395. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583308BDBM583308(US11524959, Compound 200. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 584051BDBM584051(US11524959, Compound 943.)
Affinity DataIC50: 12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583578BDBM583578(US11524959, Compound 470.)
Affinity DataIC50: 12nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583260BDBM583260(US11524959, Compound 152. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583475BDBM583475(US11524959, Compound 367. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583472BDBM583472(US11524959, Compound 364. | 4-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583584BDBM583584(US11524959, Compound 476.)
Affinity DataIC50: 13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583483BDBM583483(US11524959, Compound 375. | 4-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583496BDBM583496(US11524959, Compound 388. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 13nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583588BDBM583588(US11524959, Compound 480.)
Affinity DataIC50: 14nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583807BDBM583807(US11524959, Compound 699.)
Affinity DataIC50: 15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 584173BDBM584173(US11524959, Compound 1065.)
Affinity DataIC50: 15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583213BDBM583213(US11524959, Compound 105. | {4-[(2-{5-[(1R,4R,7R)-...)
Affinity DataIC50: 15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583314BDBM583314(US11524959, Compound 206. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 584110BDBM584110(US11524959, Compound 1052. | US11524959, Compound ...)
Affinity DataIC50: 15nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583884BDBM583884(US11524959, Compound 776.)
Affinity DataIC50: 16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583468BDBM583468(US11524959, Compound 360. | (1R,4R,7R)-2-{2-[1- (c...)
Affinity DataIC50: 16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583601BDBM583601(US11524959, Compound 493.)
Affinity DataIC50: 16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583237BDBM583237(US11524959, Compound 129. | 5-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583573BDBM583573(US11524959, Compound 483. | US11524959, Compound 4...)
Affinity DataIC50: 16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583323BDBM583323(US11524959, Compound 215. | 5-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 16nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583967BDBM583967(US11524959, Compound 859.)
Affinity DataIC50: 17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583298BDBM583298(US11524959, Compound 190. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583443BDBM583443(4-(2-{5-[(1R,4R,7R)-7-amino-2- azabicyclo[2.2.1]he...)
Affinity DataIC50: 17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583319BDBM583319(US11524959, Compound 211. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 17nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583678BDBM583678(US11524959, Compound 570.)
Affinity DataIC50: 18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583231BDBM583231(US11524959, Compound 123. | 5-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583583BDBM583583(US11524959, Compound 475.)
Affinity DataIC50: 18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583325BDBM583325(US11524959, Compound 217. | 6-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583713BDBM583713(US11524959, Compound 605.)
Affinity DataIC50: 18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583160BDBM583160(US11524959, Compound 52. | (1R,4R,7R)-2-{2-[1- (cy...)
Affinity DataIC50: 18nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583613BDBM583613(US11524959, Compound 505.)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583853BDBM583853(US11524959, Compound 745.)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583197BDBM583197(US11524959, Compound 89. | 4-(2-{5-[(1R,4R,7R)-7-a...)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 584035BDBM584035(US11524959, Compound 927.)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583831BDBM583831(US11524959, Compound 723.)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583876BDBM583876(US11524959, Compound 768.)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583466BDBM583466(US11524959, Compound 358. | 5-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583465BDBM583465(US11524959, Compound 357. | 4-(2-{5-[(1R,4R,7R)-7-...)
Affinity DataIC50: 19nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

TargetProtein-arginine deiminase type-4(Human)
Bristol-Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 583710BDBM583710(US11524959, Compound 602.)
Affinity DataIC50: 20nMAssay Description:Compounds were solubilized in 100% DMSO to achieve a 10 mM compound concentration. Compound stock solutions were stored at RT. A series of dilutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2023
Entry Details
US Patent

Displayed 1 to 50 (of 1097 total ) | Next | Last >>
Jump to: